Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Thu, 05.10.2023
Redcare Pharmacy N.V.
Redcare Pharmacy continues to successfully grow fast in all its markets.
Total sales growth 67% in Q3, to EUR 475M.
Year-to-date total sales growth 45%, to EUR 1.3bn.
Organic growth (i.e. excluding sales of MediService) 26% to EUR 358M in Q3 and 24% to EUR 1.1bn year to date.
Non-Rx growth 27% in Q3 (to EUR 319M) and year to date 26% (to EUR 97 [ … ]
Tue, 01.08.2023
Redcare Pharmacy N.V.
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M.
Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1.
Non-Rx growth 27% in [ … ]
Tue, 01.08.2023
Redcare Pharmacy N.V.
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M.
Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1.
Non-Rx growth 27% in [ … ]
Thu, 06.07.2023
Redcare Pharmacy N.V.
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Total sales growth 47% to EUR 421M in Q2.
Year to date sales EUR 793M, a growth of 34%.
Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri [ … ]
Thu, 06.07.2023
Redcare Pharmacy N.V.
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Total sales growth 47% to EUR 421M in Q2.
Year to date sales EUR 793M, a growth of 34%.
Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri [ … ]
Tue, 13.06.2023
Redcare Pharmacy N.V.
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.
With today’s event, Europe’s largest one-stop pharmacy takes another step [ … ]
Tue, 13.06.2023
Redcare Pharmacy N.V.
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.
With today’s event, Europe’s largest one-stop pharmacy takes another step [ … ]
Tue, 06.06.2023
Redcare Pharmacy N.V.
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd.
Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie [ … ]
Tue, 06.06.2023
Redcare Pharmacy N.V.
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd.
Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie [ … ]
Mon, 22.05.2023
SHOP APOTHEKE EUROPE N.V.
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig [ … ]